The effect of curcumin on septic patients

The effect of curcumin supplementation on inflammatory factors and prognosis in septic ICU patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211023052849N2

Enrollment

Registered

2022-03-09

Start date

2021-12-06

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis. Sepsis with septicemia

Interventions

Intervention 1: Intervention group: curcumin. Intervention 2: Control group: placebo.

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ??? ???? ????? ?????? ??? ???? ??? ?? 24 ???? ??????? ? ?????? ???? ???????? ???? ?? 90 mmHg ????? ?? ?????

Exclusion criteria

Exclusion criteria: entral feeding intolerance estimation of death in next 24 hours pregnancy and breast feeding systolic blood pressure less than 90 mm-Hg resistant to therapy

Design outcomes

Primary

Measure	Time frame
Length of stay in ICU. Timepoint: daily. Method of measurement: patient documents.	—

Secondary

Measure	Time frame
TNF-alpha. Timepoint: 0, 5 days after intervention. Method of measurement: ELISA.;IL-6. Timepoint: 0, 5 days after intervention. Method of measurement: ELISA.;ESR. Timepoint: 0, 5 days after intervention. Method of measurement: ELISA.;Crp. Timepoint: 0, 5 days after intervention. Method of measurement: ELISA.;CBC. Timepoint: 0, 5 days after intervention. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Heroabadi

Tehran University of Medical Sciences

aheroabadi@sina.tums.ac.ir84901

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026